CIK 0001655923
- Emerging growth company
Alpha Cognition Inc.
Sign in to watch- Ticker
- ACOG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 858-344-4375
- Business address
- 1452 HUGHES RD., STE. 200, GRAPEVINE, TX, 76051
- Former names
- Neurodyn Cognition Inc.
- Open-market buys, last 90 days
- $2,169,536
- in 6 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,169,536. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-09 | McFadden Michael E. Chief Executive Officer | Grant or award | +190,549 | 190,549 | ||
| 2026-01-09 | McFadden Michael E. Chief Executive Officer | Grant or award · Common Share Options | +177,576 | 177,576 | ||
| 2026-01-09 | McFadden Michael E. Chief Executive Officer | Grant or award · Performance Share Units | +76,220 | 76,220 | ||
| 2025-02-25 | McFadden Michael E. Chief Executive Officer | Grant or award · Common Share Options | +496,947 | 496,947 | ||
| 2024-11-13 | McFadden Michael E. Chief Executive Officer | Purchase | +2,608 | $5.75 | $15K | 14,142 |
Page 1 of 1 · 5 trades